San Diego, CA, United States of America

Jianwei Che

USPTO Granted Patents = 6 

 

 

Average Co-Inventor Count = 3.9

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Jianwei Che in Cancer Treatment

Introduction

Jianwei Che is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel chemical compounds. With a total of 6 patents, his work focuses on inhibitors of mutant isocitrate dehydrogenases, which are crucial in the fight against cancer and related diseases.

Latest Patents

One of Jianwei Che's latest patents is titled "Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof." This invention provides novel chemical compounds that are useful for treating cancer or related diseases. The patent also includes pharmaceutical compositions and methods of preparation and use, showcasing the potential impact of his work on cancer therapies.

Career Highlights

Throughout his career, Jianwei Che has worked with various companies, including Irm LLC and Isocure Biosciences Inc. His experience in these organizations has allowed him to further develop his innovative ideas and contribute to advancements in medical science.

Collaborations

Jianwei Che has collaborated with notable coworkers such as Qiang Ding and Yahua Liu. These partnerships have played a vital role in enhancing his research and expanding the scope of his inventions.

Conclusion

Jianwei Che's contributions to cancer treatment through his innovative patents highlight the importance of research and development in the medical field. His work continues to pave the way for new therapeutic options for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…